MedPath

Continuous Versus Repetitive Sevoflurane Administration for Preconditioning

Phase 4
Completed
Conditions
Myocardial Injury
Interventions
Registration Number
NCT00569816
Lead Sponsor
University Hospital Schleswig-Holstein
Brief Summary

Pharmacologic preconditioning by volatile anesthetics may depend on the mode of administration. The researchers hypothesize that a continuous administration in patients scheduled for CABG surgery prebypass will be less effective in terms of attenuating myocardial cell damage compared to a repetitive administration with a double wash in/wash out schedule. A control group will receive propofol as their primary anesthetic.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
50
Inclusion Criteria
  • Patients schedulded to undergo CABG surgery
  • Age 18 to 80 years
  • Ejection fraction > 40%
Exclusion Criteria
  • Emergency cases
  • Diabetes
  • Not able to give informed consent
  • Ejection fraction < 40%

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Group 2SevofluraneSevoflurane administered continuously after induction of anesthesia until initiation of cardiopulmonary bypass.
Group 1SevofluranePropofol as the primary anesthetic
Group 3SevofluraneSevoflurane administered repetitive up to 1 MAC from induction of anesthesia until initiation of cardiopulmonary bypass. Wash in and wash out performed twice.
Primary Outcome Measures
NameTimeMethod
Myocardial cell damage as assessed by plasma levels of Troponin Tfrom induction of anesthesia until hospital discharge
Secondary Outcome Measures
NameTimeMethod
Length of stay on the ICU and in the hospitalfrom hospital admission until hospital discharge

Trial Locations

Locations (1)

University Hospital Schleswig-Holstein, Campus Kiel

🇩🇪

Kiel, Germany

© Copyright 2025. All Rights Reserved by MedPath